The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for UTI Mutual Fund
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
UTI Mutual Fund, together with four persons acting in concert (PACs), has disclosed a small open-market purchase of 25,253 equity shares (0.0456%) of Rossari Biotech on May 6, 2025. This takes UTI MF's combined holding in the company from 7.0235% (38,88,675 shares) to 7.0691% (39,13,928 shares). The acquirer is not part of the promoter group, and the deal was executed on the secondary market. This is a routine Regulation 29(2) SAST disclosure filed because UTI MF already holds more than 5% in the company.
This is a minor incremental buy by an institutional investor and is unlikely to materially impact the stock price. It signals continued institutional interest but represents a very small change in ownership stake.